Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
State control of remote hosts for management of distributed applications
Limit switch
Methods, systems, and products for searching interactive menu prompting systems
Method and apparatus for reducing and controlling highway congestion to save on fuel costs
Fuse part in semiconductor device and method for forming the same
Method and device for operating a vehicle having a hybrid drive
Method and system for processing dictated information
  Randomly Featured Patents
Immersion coating system
Substrate design for optimized performance of up-conversion phosphors utilizing proper thermal management
Data processing apparatus and data processing method
Method for producing a high-quality insulation of electric conductors or conductor bundles of rotating electrical machines by means of spray sintering
Face recognition in a digital imaging system accessing a database of people
Metalworking lubricant composition containing a novel substituted malonic acid diester
Apparatus and method for impregnating a dry fiber batt
Programmable electronic speed control
In vivo production of cyclic peptides